on 24 May 2022
Last Applicant/ Owned by
5th Floor
Copenhagen
DK
2100
Serial Number
90341701 filed on 25th Nov 2020
Registration Number
6727299 registered on 24th May 2022
Correspondent Address
Stacy J. Grossman
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations for antibacterial treatments, microbiome modulating treatments, anti-infective Read More
Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations for antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; antibiotic preparations; pharmaceutical preparations, namely, antiviral preparations; probiotic supplements; probiotic supplements for medical use; probiotic formulations for veterinary use, namely, probiotic nutritional supplements; probiotic formulations for medical use, namely, probiotic nutritional supplements; enzymes of microbiome modulators for veterinary purposes, namely, animal feed additives for use in animals feed to assist in digestion; enzymes of microbiome modulators for medical purposes, namely, targeted antimicrobial treatments for disease prevention or alteration; guided nuclease-based biocides; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis and testing in the field of diseases and conditions associated with bacteria; industrial analysis and industrial research services; design and development of computer hardware and software; genetic microbiology and microbiome research; genetic engineering and services; design and development of hardware and software; clinical research; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of guided nuclease-based biocides; conducting clinical trials for others; clinical research; conducting clinical trials for pharmaceutical products; bacteriological research; viral research; biological research; scientific and medical screening and assaying; chemical analysis; chemical research
Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons in the nature of diagnostic and treatment counselling regarding the treatment of conditions and disease; pharmaceutical advice; medical and health services relating to DNA, genetics and genetic pathogen testing, namely, genetic testing for medical purposes; genetic counselling; medical screening and assaying
No 90341701
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
24th May 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
24th May 2022 | REGISTERED-PRINCIPAL REGISTER |
01st Mar 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
01st Mar 2022 | PUBLISHED FOR OPPOSITION |
09th Feb 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
24th Jan 2022 | ELECTRONIC RECORD REVIEW COMPLETE |
07th Jan 2022 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
03rd Jan 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
24th Nov 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
23rd Nov 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |